Millennium Management’s NeoGenomics NEO Stock Holding History

Millennium Management’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-12,000	Closed	-$198K	–	6225
2024 Q4	$198K	Sell	12,000 -18,000	-60%	-$280K	﹤0.01%	5311
2024 Q3	$443K	Buy	+30,000	New	+$469K	﹤0.01%	4923
2024 Q1	–	Sell	-50,000	Closed	-$809K	–	6492
2023 Q4	$809K	Buy	+50,000	New	+$818K	﹤0.01%	4316
2022 Q2	–	Sell	-25,000	Closed	-$304K	–	7312
2022 Q1	$304K	Buy	+25,000	New	+$526K	﹤0.01%	5527

Other funds holding NEO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Millennium Management's NEO Position: Q1 2026 in Review

Millennium Management reduced its NeoGenomics (NEO) stake by 57% in Q1 2026, selling an estimated $31.4M and leaving 2,222,757 shares worth $16.5M. The position accounts for 0.01% of the portfolio, ranked #1706.

Millennium Management first reported a position in NEO in Q4 2013 and has held it in 39 quarters since. The position peaked at $63.8M in Q1 2025. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.

Millennium Management held 2,222,757 shares of NeoGenomics worth $16.5M as of Q1 2026.
Millennium Management sold 2,981,652 NeoGenomics shares in Q1 2026, an estimated $31.4M.
NeoGenomics made up 0.01% of Millennium Management's portfolio in Q1 2026, its #1706 holding.
Millennium Management first reported a position in NeoGenomics in Q4 2013 and has held it in 39 quarters since.
Millennium Management's NeoGenomics position peaked at $63.8M in Q1 2025.
253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.